SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

[Clostridium] polysaccharolyticum Details: NCBI 29364, gram-negative or unknown [species]

| [Clostridium] polysaccharolyticum| ATCC 33142| Clostridium polysaccharolyticum| Clostridium polysaccharolyticum (van Gylswyk 1981) van Gylswyk et al. 1983| DSM 1801| Fusobacterium polysaccharolyticum| Fusobacterium polysaccharolyticum van Gylswyk 1981| strain B

  1. Gut microbiota: Clostridium species are commonly found in the human gut microbiota, where they play important roles in fermentation, metabolism, and immune regulation. While some Clostridium species are considered beneficial and contribute to gut health, others may be opportunistic pathogens under certain conditions. Clostridium difficile, for example, is a well-known pathogen that can cause antibiotic-associated diarrhea and pseudomembranous colitis.

  2. Fermentation and metabolism: Clostridium polysaccharolyticum, like other members of the genus, is capable of fermenting complex carbohydrates, such as polysaccharides, into simpler compounds like short-chain fatty acids (SCFAs) and gases. These metabolic byproducts can have diverse effects on host physiology, immune function, and gut barrier integrity.

  3. Pathogenicity: While Clostridium polysaccharolyticum is not commonly associated with human disease, some Clostridium species are known to produce toxins and enzymes that can cause illness in humans. Clostridium botulinum produces botulinum toxin, which can cause botulism, a severe and potentially life-threatening illness characterized by muscle weakness, paralysis, and respiratory failure. Clostridium perfringens produces toxins that can cause gas gangrene, necrotizing enteritis, and food poisoning.

  4. Opportunistic infections: Clostridium species, including Clostridium polysaccharolyticum, have been implicated in opportunistic infections, particularly in healthcare settings. Infections with Clostridium species can occur following surgical procedures, invasive medical interventions, or prolonged antibiotic therapy. Clostridium difficile infections, in particular, have become a significant public health concern due to the emergence of antibiotic-resistant strains and the associated morbidity and mortality.

  5. Potential probiotic properties: While most research on Clostridium species has focused on their pathogenic potential, some strains may have probiotic properties and could be beneficial for gut health. Clostridium species capable of producing SCFAs, such as butyrate, may have anti-inflammatory and immunomodulatory effects in the gut. However, further research is needed to evaluate the safety and efficacy of Clostridium-based probiotics for human use.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for [Clostridium] polysaccharolyticum

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.44 30 2426 0 1785 332.8 65 740.9 30 2426 8.3 %ile 83.3 %ile
thryve 84.66 0 328 41 526 0 4675 494.9 140 2132.7 0 590 11.9 %ile 90.3 %ile

External Reference Ranges for [Clostridium] polysaccharolyticum

[Clostridium] polysaccharolyticum (NCBI 29364) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for [Clostridium] polysaccharolyticum
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSightRdp 15.625 %   0.01 %  0.009 % 5.0 32
custom 5.085 %   0.084 %  0.138 % 3.0 59
SequentiaBiotech 2.778 %   0.027 %  % 1.0 36
Thryve 86.045 %   0.046 %  0.197 % 1190.0 1383

Symptoms Associated with [Clostridium] polysaccharolyticum From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Amino Acid and similar Theanine 1 Studies recorded. The consensus is Decreases📓, Click for details.
Common Supplements Exercise 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high-fat diets 1 Studies recorded. The consensus is Decreases📓, Click for details.
flavonoids, polyphenols etc quercetin,resveratrol 1 Studies recorded. The consensus is Decreases📓, Click for details.
flavonoids, polyphenols etc Rutin 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) Astragalus 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) blueberry 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) cranberry bean flour 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) walnuts 1 Studies recorded. The consensus is Increases📓, Click for details.
Herb or Spice Citrus Fruit Extract 1 Studies recorded. The consensus is Decreases📓, Click for details.
Herb or Spice Dangshen 1 Studies recorded. The consensus is Increases📓, Click for details.
Herb or Spice rosmarinus officinalis,rosemary 1 Studies recorded. The consensus is Decreases📓, Click for details.
Herb or Spice Slippery Elm 2 Studies recorded. The consensus is Increases👶, Click for details.
Prebiotics and similar carboxymethyl cellulose (prebiotic) 1 Studies recorded. The consensus is Increases📓, Click for details.
Prebiotics and similar Human milk oligosaccharides (prebiotic, Holigos, Stachyose) 1 Studies recorded. The consensus is Increases📓, Click for details.
Prebiotics and similar inulin (prebiotic) 1 Studies recorded. The consensus is Increases📓, Click for details.
Prescription - Other heparin 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prescription - Other monensin sodium salt,(prescription) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prescription - Other risperidone,(prescription) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Probiotics bacillus subtilis (probiotics) 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics saccharomyces boulardii (probiotics) 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics vsl#3 (probiotics) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Vitamins, Minerals and similar iron 1 Studies recorded. The consensus is Increases📓, Click for details.
Vitamins, Minerals and similar vitamin a 1 Studies recorded. The consensus is Increases📓, Click for details.
Vitamins, Minerals and similar Vitamin B9,folic acid 1 Studies recorded. The consensus is Increases📓, Click for details.
Vitamins, Minerals and similar zinc 2 Studies recorded. The consensus is Decreases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)